Elektron Technology
Follow Elektron Technology on TwitterFollow Elektron Technology on LinkedinElektron technology on YouTubeElektron Technology on Flickr

Elektron Technology

Cette maladie est responsable d'une atteinte musculaire par anomalie du métabolisme du glycogène. Comme l'enzyme défectueuse est localisée cialis cialispharmaciefr24 au niveau du lysosome, cette maladie est souvent classée comme une maladie de surcharge lysosomale.


Welcome to Elektron Technology’s Investor Relations Centre. Elektron Technology plc is listed on AIM, part of the London Stock Exchange.

In accordance with AIM Rule 26, as stipulated by the London Stock Exchange, all AIM-quoted companies are required to disclose certain information on their corporate website.

In compliance with this rule, Elektron Technology plc (incorporated in England & Wales registered number 448274) has provided the required information on this site. Please use the links on the right to browse investor information.